Primary B cell engineering for therapeutic research.
Trends in molecular medicine, 28(6): 528-529 PMID 35430120 DOI 10.1016/j.molmed.2022.03.007
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.